From sensible skincare to slightly chaotic wellness territory.

Woman swimmer adjusting red goggles in a gold swim cap after training

From collagen powder to injectable “stacks”, wellness has made one familiar word much harder to decode.

Peptides are easy until you leave the bathroom. In skincare, we know the drill: serums promising firmer skin, better repair and a little more resilience where collagen has started to clock off. They feel familiar, clever and reassuringly evidence-adjacent. Then wellness gets hold of the word and suddenly someone is injecting a peptide for a tendon injury, someone else is taking one for sleep, another is talking about metabolism and longevity, and your collagen powder is apparently part of the same family.

Except it isn’t quite that simple. A peptide can be a cosmetic ingredient, a supplement, a licensed medicine or an experimental injectable — and those things do not become interchangeable just because they share a name. Some have decades of research behind them. Some are genuinely promising but still early. Some are being used in the US in ways that would be much harder to access here. And some come with the sort of “research use only” disclaimer that should probably make you sit up a little straighter.

Which is how a word most of us thought we understood has become one of wellness’s most confusing catch-alls. What actually happens when you swallow a peptide rather than inject it? Why are some completely legitimate medicines while others sit in a regulatory no-man’s-land? And if everyone from dermatologists to biohackers is suddenly talking about them, which bits are worth paying attention to — and which are just very expensive optimism? That’s the bit we’re clearing up.

Same Family, Completely Different Lives

Strip away the serum bottles, longevity clinics and men discussing “protocols” on podcasts, and a peptide is simply a short chain of amino acids. Your body makes them naturally, and many act as messengers, helping to tell cells what to do. The important bit is that different peptides can send very different messages — which is why the word itself tells you surprisingly little.

“The problem is that the confidence around these peptides has travelled faster than the human evidence.”

In skincare, that might mean peptides used in formulas designed to support collagen or skin repair. In medicine, a peptide can be developed to mimic or influence a hormone or another biological process. And if you have a tub of collagen peptides next to the Nutribullet, that is another version again: collagen protein that has been broken down into smaller chains before you drink it.

This is where a lot of us understandably lose the plot. If your serum contains peptides, your protein powder says peptides and somebody on Instagram is injecting a peptide into their stomach, are we really talking about the same thing? Technically, they belong to the same broad molecular family. Practically, they can behave very differently.

How they enter the body is part of that. Swallow collagen peptides and digestion gets involved, breaking them down further before they are absorbed. Inject a biologically active peptide and you bypass the gut, allowing that molecule to reach the body in a form that can deliver a much more specific biological signal. It is one reason an injectable peptide can behave more like a drug than anything you are scooping into a morning smoothie.

Peptides Were Medicine Long Before They Were Wellness

Before the longevity crowd claimed them, peptides already had a perfectly respectable day job. Insulin is a peptide hormone, while peptide-based drugs are used across mainstream medicine. GLP-1 medicines sit in this wider world too, alongside treatments used in areas including diabetes and osteoporosis.

Which makes the current “are peptides good or bad?” debate slightly absurd. Your peptide eye serum, Wegovy and an unapproved vial of BPC-157 are not three versions of the same wellness trend. The name tells you about the molecule; it does not tell you whether something is effective, safe or worth £300 a month.

BPC-157. TB-500. MOTS-C. CJC-1295. Ipamorelin. They sound less like a wellness routine and more like the Wi-Fi passwords at a particularly expensive gym, but these are the names beginning to creep into conversations about recovery, muscle, metabolism, sleep and longevity.

Close-up of swimmer in gold cap and red goggles looking towards camera

BPC-157 has become the poster child for injury recovery, particularly tendons and soft tissue. TB-500 is talked about in similar healing circles. MOTS-C is attracting interest around metabolism and healthy ageing, while CJC-1295 and ipamorelin sit in the growth-hormone conversation. There are real biological reasons scientists are interested in them. The problem is that the confidence around these peptides has travelled faster than the human evidence.

And once you start hearing the stories, you can see how that happens. A runner says their tendon finally stopped hurting. Someone else is sleeping through the night for the first time in years. A man with a microphone has a “stack” involving four compounds, an ice bath and presumably no fear whatsoever of needles. Give those stories enough airtime and something still being studied can begin to feel like established medicine remarkably quickly.

The science underneath it is not imaginary. It is simply unfinished. For several of these peptides, we still do not have the sort of large, high-quality human trials that would answer the decidedly unsexy questions: how well does it work, for whom, at what dose, for how long and what happens after years rather than weeks? In the US, the FDA has also flagged limited safety data and potential risks around compounds including BPC-157, CJC-1295 and ipamorelin.

Why America Got There First

Part of the reason peptides feel so much further along in the US is something called compounding. In plain English, a pharmacist or doctor can mix or alter a medicine to meet the needs of a particular patient — perhaps changing the dose, removing an ingredient they cannot tolerate or turning a tablet into a liquid. It is a legitimate and useful part of healthcare.

But compounded medicines are not FDA-approved in the same way as standard licensed drugs. The FDA does not review them for safety, effectiveness or quality before they reach patients, even though they may be prescribed and supplied through a medical setting. That distinction is easy to miss when everything arrives with a consultation, a needle and enough medical vocabulary to make Google unnecessary.

It also helps explain why the peptide conversation can feel as though it is happening at full volume in Los Angeles while the UK and Europe are still considerably more cautious. Here, unlicensed medicines can be supplied in specific circumstances for individual clinical need, but they sit within tighter regulatory routes rather than simply becoming another item on a wellness menu.

Peptides sit in an unusually seductive bit of modern wellness: serious enough to sound medical, shiny enough to feel new, and just complicated enough that most of us are unlikely to interrogate every claim over dinner. Some already underpin transformative medicines. Some of the newer ones may eventually earn their place alongside them. Others may have a very successful podcast career, a brief stint in a fridge drawer and then quietly disappear once the research catches up.

The trick is not getting dazzled by the category. “Peptide” now has the same kind of glow as “clinical”, “biohacking” and “longevity” — impressive on contact, but not terribly useful on its own. The interesting question is still the one nobody puts in the headline: what does this one actually do, and is the science keeping up with the hype?